Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease

被引:52
作者
Soman, P
Taillefer, R
DePuey, EG
Udelson, JE
Lahiri, A [1 ]
机构
[1] Northwick Pk Hosp, Dept Cardiovasc Med, NHS Trust & Inst Med Res, Harrow HA1 3UJ, Middx, England
[2] St Marks Hosp, Dept Cardiovasc Med, NHS Trust & Inst Med Res, Harrow HA1 3UJ, Middx, England
[3] Hotel Dieu, Dept Nucl Med, Montreal, PQ, Canada
[4] St Lukes Roosevelt Hosp Ctr, Div Nucl Med, New York, NY USA
[5] New England Med Ctr, Div Cardiol, Boston, MA 02111 USA
关键词
D O I
10.1016/S0735-1097(00)01148-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We prospectively compared dipyridamole single-photon emission computed tomography (SPECT) imaging with Tc-99m sestamibi and Tc-99m tetrofosmin for the detection of reversible perfusion defects in patients with mild-to-moderate coronary artery disease. BACKGROUND Tc-99m tetrofosmin has a lower first-pass myocardial extraction fraction compared to Tc-99m sestamibi and thus could underestimate mild perfusion defects. METHODS Eighty-one patients with 50% to 90% stenosis in one or two major epicardial vessels without previous myocardial infarction, and seven with <5% probability of coronary artery disease underwent dipyridamole SPECT imaging with both agents. The SPECT data were analyzed quantitatively. RESULTS Tc-99m sestamibi detected reversible perfusion defects in a greater number of segments (total 363 and 285, p < 0.001, and mean +/- SD, 2.2 +/- 3.0 and 1.8 +/- 2.5 per patient, p = 0.008, for Tc-99m sestamibi and Tc-99m tetrofosmin, respectively), demonstrated a lamer extent of perfusion defect (mean +/- SD, 15.8% +/- 12.3% and 12.0% +/- 11.4%, p < 0.03, for Tc-99m sestamibi and Tc-99m tetrofosmin, respectively) and more often correctly identified patients with disease in more than one coronary artery (p = 0.02). There was better defect contrast with Tc-99m sestamibi (defect/normal wall count ratios were 0.60 +/- 0.15 vs. 0.73 +/- 0.14 for Tc-99m sestamibi and Tc99m tetrofosmin, respectively, p = 0.01:, for reversible defects seen in identical segments with both agents; and 0.73 +/- 0.16 vs 0.79 +/- 0.17, respectively p < 0.01, for reversible defects detected with either agent alone). There was no significant difference in diagnostic sensitivity or image quality. CONCLUSIONS These differences between two commonly used tracers may have significant diagnostic and prognostic implications. (C) 2001 by the American College of Cardiology.
引用
收藏
页码:458 / 462
页数:5
相关论文
共 38 条
[1]   Direct comparison of technetium 99m sestamibi and technetium 99m tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease [J].
Acampa, W ;
Cuocolo, A ;
Sullo, P ;
Varrone, A ;
Nicolai, E ;
Pace, L ;
Petretta, M ;
Salvatore, M .
JOURNAL OF NUCLEAR CARDIOLOGY, 1998, 5 (03) :265-274
[2]   EXPERIMENTAL STUDIES OF THE PHYSIOLOGICAL-PROPERTIES OF TC-99M ISONITRILES [J].
BELLER, GA ;
SINUSAS, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (13) :E5-E8
[3]  
BELLER GA, 1995, CLIN NUCL CARDIOLOGY, P37
[4]   INCREMENTAL VALUE OF PROGNOSTIC TESTING IN PATIENTS WITH KNOWN OR SUSPECTED ISCHEMIC-HEART-DISEASE - A BASIS FOR OPTIMAL UTILIZATION OF EXERCISE TC-99M SESTAMIBI MYOCARDIAL PERFUSION SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY [J].
BERMAN, DS ;
HACHAMOVITCH, R ;
KIAT, H ;
COHEN, I ;
CABICO, JA ;
WANG, FP ;
FRIEDMAN, JD ;
GERMANO, G ;
VANTRAIN, K ;
DIAMOND, GA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (03) :639-647
[5]   DIPYRIDAMOLE PERFUSION SCINTIGRAPHY [J].
BOTVINICK, EH ;
DAE, MW .
SEMINARS IN NUCLEAR MEDICINE, 1991, 21 (03) :242-265
[6]   A TEST FOR SYMMETRY IN CONTINGENCY TABLES [J].
BOWKER, AH .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1948, 43 (244) :572-574
[7]   Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease [J].
Boyne, TS ;
Koplan, BA ;
Parsons, WJ ;
Smith, WH ;
Watson, DD ;
Beller, GA .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (03) :270-274
[8]  
BROWN KA, 1994, J NUCL MED, V35, P554
[9]  
DAHLBERG ST, 1999, NUCL CARDIOLOGY STAT, P27
[10]   ANALYSIS OF PROBABILITY AS AN AID IN THE CLINICAL-DIAGNOSIS OF CORONARY-ARTERY DISEASE [J].
DIAMOND, GA ;
FORRESTER, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (24) :1350-1358